보도자료

NEXT SCIENCE subsidiary decided to increase the paid-up capital of 4.16 billion won

작성자
admin
작성일
2019-03-18 10:49
조회
166
NEXT SCIENCE announced on Dec. 25 that its subsidiary, Dandi Bioscience, has decided to increase the paid-up capital of 4.16 billion won. The new issue price is 3,000 won, and the new scale is 1,380,277 shares of common stock. The application date is 27th of next month.